Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04628026
Title Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Ulm
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.